Mid-Size Japanese Device Makers Shift Market Focus To China
This article was originally published in PharmAsia News
Medium-sized makers of medical devices in Japan are shifting their focus to China and its larger market as a solution to their shrinking domestic market.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.